Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.01−0.27 (-2.86%)
Close on Nov 18, 2026Market cap $579.84MP/E –Yield –
Cullinan Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cullinan Therapeutics's pe ratio was 8.5× on Jul 31, 2023.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 8.5× | +3.7 |
| 2022 | Dec 30, 2022 | 4.8× | – |
See a number that looks wrong?